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Abbreviations
5-ALA : 5-aminolevulinic acid
HAL : Hexaminolevulinate
PAPs : Photoactive Porphyrins
PI  : Propidium Iodide
ROS : Reactive Oxygen Species
Introduction
 Photodynamic therapy is growing as an alternative treatment 
for different types of cancer, like an invasive bladder cancer. 
Photodynamic therapy is a technique that consists basically of two 
components - a photosensitizer drug and specific illumination - which 
individually result in little to no toxicity. When both are combined they 
induce a photochemical reaction inside the cell and in the presence of 
oxygen generate oxygenated products like superoxide (·-O2), 
Hydrogen Peroxide (H2O2) and Hydroxyl Radicals (˙OH). These 
Reactive Oxygen Species (ROS) cause toxicity and finally cell death 
[1,2]. ROS generated through these mechanisms accumulate inside 
malignant cells, close to mitochondria since protoporphyrin IX is 
synthesized in this organelle [3], and subsequently, ROS oxidize 
intracellular molecules therefore destroying cells. The photodynamic 
toxicity is due to ROS which have high reactivity with short half-life 
time (<0.04μs) [1]. Photodynamic therapy can be used along with 
other common cancer treatments such as surgery, chemotherapy and/
or radiotherapy without affecting its performance, but the character-
istic adverse effects of these therapies are absent in photodynamic 
treatment [2]. This technique can also be delivered to the patient in 
an ambulatory way, reducing health costs associated with treatment 
compared with other therapies. Clinical applications of photodynamic 
therapy in other fields of medicine include treatments of age related 
macular degeneration and other eye diseases in ophthalmology, and 
also applications in cardiology, dermatology and rheumatology [1].
 Hexvix (hexaminolevulinate hydrochloride) is a compound 
produced by Photocure [3] ASA (Oslo, Norway) and is FDA-approved 
for photodynamic detection of cancer cells in the bladder in United 
States and Europe. This technique improves the quality of bladder 
cancer diagnosis by enhancing the contrast between normal and 
tumour tissue, based on the fluorescence properties of Photoactive 
Porphyrins (PAPs) and their affinity to malignant cells [4]. 
Hexaminolevulinate (HAL) is a derivative of 5-Aminolevulinic Acid 
(5-ALA), being a precursor of PAPs, mainly protoporphyrin IX. 
After incubation of Hexvix on bladder, protoporphyrin IX generated 
inside the cancer cells emits red light fluorescence under blue light 
(400 nm) illumination. The intake of HAL administration turned out 
to have increased preference on cells with a high rate of proliferation, 
such as neoplastic tissues [5,6], although the mechanisms involved in 
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Abstract
 Photodynamic therapy is an emerging treatment used for 
certain types of cancer, where a photosensitizer drug generates 
a phototoxic effect on cells when exposed to light of a certain 
wavelength. Hexvix is a photosensitizer used in blue light 
cystoscopy, used to detect bladder cancer facilitating diagnosis and 
treatment of this disease. This compound is selectively absorbed 
by cancer cells and not by normal cells. Illuminated with blue light, 
Hexvix emits red light, resulting in detection of cancer cells. In this 
work the potential of Hexvix to label and kill multiple cancer cell 
lines is tested, for potential clinical applications in photodynamic 
therapy. Here a microscopy cell-based assay was established with 
automated cell quantification and analysis, to investigate the 
photodynamic toxicity of Hexvix tested on six cell lines: two 
non-cancerous (MDCK and HEK293) and four cancer cell lines 
(bladder cancer (5637), prostate cancer (PC3), colon cancer 
(SW480) and breast cancer (MDA-MB-231). Results show a 
higher sensitivity to Hexvix treatment in three cancer cell lines 
(bladder, prostate and colon cancer) at lower light doses than in 
non-cancer cell lines. On the other hand, a breast cancer cell line 
showed low response to the treatment, indicating that the Hexvix 
phototoxic effect varies between cell types and requires evaluation 
for each case. The phototoxicity assay presented in this study can 
be applied as a new clinical diagnostic approach prior to 
photodynamic treatment.
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their selectivity is not yet clear. This effect allows the application of this 
compound in photodynamic diagnosis of non-invasive bladder cancer 
and also helps guide surgical resectioning of malignant tissue.
 The extent of the photo-damage and cytotoxicity of photodynam-
ic therapy relies mainly on the photosensitizer used, along with other 
factors such as photosensitizer concentration, tissue and intracellular 
localization, time and dose administrated, light exposure and drug 
incubation time prior to photodynamic therapy [1].
 The aim of this study is to evaluate Hexvix as a potential 
candidate for photodynamic therapy by selectively killing cancer 
cells, while leaving normal cells intact. This will be carried out using 
blue light (405nm), currently used for photodynamic diagnosis. We 
established a microscopy cell-based assay with automated cell 
quantification and analysis to investigate the photodynamic toxicity 
of Hexvix. A range of Hexvix concentrations and blue light exposure 
times have been tested throughout this assay, using two non-cancer 
and four cancer cell lines. This is to evaluate the potential of Hexvix to 
label and kill malignant tissue other than non-cancerous cells, and its 
potential clinical application.
Materials and Methods
Cell culture
 Six different cell lines were studied (Table 1). All cell lines were 
maintained in Dulbecco’s Modified Eagles’s Medium with phenol red 
(DMEM, Sigma, D5546) supplemented with 10% fetal bovine serum 
(Sigma, F7524), 100 μg/mL penicillin, 100 μg/mL streptomycin 
(Sigma, P4333) and 2mM GlutaMAX (Gibco, 35050-061). Cells were 
kept for incubation at 37°C, 5% CO2 in a humidified atmosphere.
 For trypsinization, DMEM medium was removed and cells 
were washed three times with phosphate buffered saline solution 
(PBS, Thermo Scientific, BR0014) pH 7.4. After washing, cells were 
incubated with 0.25% Trypsin-EDTA with phenol red (Gibco, 
25200-056) for 5 minutes at 37°C. Cell detachment was checked 
by observation under the microscope and counting was performed 
manually using an haemocytometer slide as described elsewhere [7]. 
200μL of 100,000 to 200,000 cells/mL suspensions were seeded on 
96 well plates in DMEM pre-warmed to 37oC DMEM medium for 
Hexvix phototoxicity experiments on 96 well plates (Ibidi, 89626) and 
left in the incubator overnight for cell attachment and spreading.
Hexvix treatment
 For bladder instillation using blue light cystoscopy in the clinic, 
50mL of 8mM Hexvix reconstituted solution is used and incubated 
one hour prior to cystoscopy diagnosis [6,8]. Due to the difference 
between in vitro cell monolayers and tissue in vivo, it was decided 
to evaluate Hexvix phototoxicity at multiple concentrations, starting 
with a 1:20 dilution of Hexvix (400μM), to define optimal concentra-
tions for subsequent experiments. After overnight incubation, DMEM 
medium was removed and cells were washed once with pre-warmed 
PBS and 200μL of DMEM medium was added to the control wells, 
whereas 200μL of DMEM + Hexvix (Ipsen, Photocure ASA, Oslo, 
Norway) was added to the other wells in the following concentrations: 
400μM, 50μM, 25μM, 1μM or 5μM. In order to detect 
and quantify dead cells throughout the experiment, 0.5mM 
Propidium Iodide (PI, Cayman Chemical Company, 10008351) was 
also added to cells in this step. Cells were then incubated 1-1.5 hours 
prior to image acquisition and light treatment, at 37°C, 5% CO2 in a 
humidified atmosphere. Distribution of wells and experiment setup 
can be observed in Supplementary figure 1.
Image acquisition
 Fully automated inverted Nikon Eclipse Ti-E microscope (Nikon, 
Japan), equipped with a live cell incubation chamber, a 10x Plan Apo 
N.A. 0.45 DIC dry objective was used for imaging using epifluores-
cence via a TIRF condenser allowing sample exposure to non-filtered 
maximal laser light. Detection was performed using an Andor 
EMCCD camera iXon model 885 (Oxford Instruments, Belfast, 
United Kingdom). Images were acquired using Andor iQ3.3 
(Oxford Instruments, Belfast, United Kingdom). Time-lapse images 
were acquired every 10 minutes for 500 minutes, generating a set of 50 
frame sequences per field (in TIFF format) for analysis. Each well was 
sampled in three different fields of view.
 Images were acquired in three channels: 1) Transmission light 
differential interference contrast (DIC) to image cell morphology and 
count total cells. Light source = tungsten bulb 100W, 2) Fluorescent 
light detection with 600nm LP emission filter upon 560nm solid state 
laser illumination (laser output power 50mW) to detect PI signal from 
dead cells, and 3) Fluorescent light detection with 593nm LP emission 
filter upon 405nm solid state laser illumination (laser output power 
100mW), to detect protoporphyrin IX signal from Hexvix positive 
cells. Additionally, for photodynamic treatment, cells were exposed 
to 405nm (laser output power 100mW) illumination for five, three 
or one second. No signal was detected by this illumination. Detailed 
experiment setup can be observed in Supplementary figure 1.
Cell line Species Origin
MDCK Canis familiaris Kidney, normal
HEK293 Homo sapiens Embryonic kidney, normal
5637 Homo sapiens Urinary bladder, grade II carcinoma
PC3 Homo sapiens Prostate, grade IV adenocarcinoma
SW480 Homo sapiens Colon, grade III-IV adenocarcinoma
MDA-MB-231 Homo sapiens Breast, pleural effusion adenocarcinoma
Table 1: Summary of  cell lines used.
Supplementary Figure 1: Image acquisition setup. Seeded cells were incubated for 
1-1.5 hours with the correspondent Hexvix concentration, together with 0.5mM of  
PI for cell death detection. After, image acquisition and light treatment was per-
formed, acquiring 3 different channels in each position: DIC bright field, Photo por-
phyrin IX (PpIX) signal by 405nm light illumination and PI signal by 560nm light 
illumination. 405nm light treatment was applied for 5, 3 or 1 second during the image 
acquisition process, and no 405nm light was used a control. Three positions were 
imaged by each well 50 times. Each cell line was treated separately according to this 
setup.
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Image processing and cell counting
 Images acquired were firstly processed using Image J/Fiji 
software (National Institute of Health, USA), then the processed images 
were used for automated cell counting using Cell Profiler software ver-
sion 2.1.1 (National Institute of Health, USA). Total cell counting was 
obtained from DIC images and dead cell counting was obtained 
from PI positive cells. Details of processing and Cell profiler pipeline 
settings can be found in supplementary materials section.
 For time-lapse images and video file preparation, bright field DIC 
images were improved by flat field correction as described previously 
and fluorescence images were improved by background subtraction 
tool with rolling ball of 50px in Fiji software.
Data analysis
 Data acquired using Cell Profiler software was sorted using 
Microsoft Excel 2007 Software. To obtain dead cell fractions, total 
dead cell counts were divided by total cell value. Three images per 
well/condition were taken. The triplicate values were averaged and 
standard deviation values were calculated.
 To determine accuracy of automated cell counting, cells were 
manually counted in one image from five separate wells for each cell 
line. These values were compared to the automated counting values of 
the same set of images. To obtain accuracy percentage Equation 1 was 
used based on binary classification [9].
            (1)
 True positives: manually counted cells,  true negatives: none, false 
positives: value of automated counted cells over manually counted 
cells, false negatives: value of automated counted cells under manually 
counted cells.
 Accuracy percentages are described in table 2. Based on 
these values it was considered this type of image processing and 
automated counting was an appropriate technique for counting DIC 
images of adherent cells, therefore all image results were achieved 
using this method.
Statistics
 2-way ANOVA and Bonferroni post test with a 5% significance 
level was used for the statistical calculations. Results are expressed as 
mean ± Standard Error of the Mean (SEM).
Results
Hexvix at 10-50μM is the effective concen-
tration range for a photodynamic effect in 
bladder carcinoma cells in vitro
 Non cancerous cell line MDCK and bladder cancer cell line 5637 
were treated with different concentrations of Hexvix, ranging from 
400μM to 5μM, in order to define the window of optimal concentra-
tions to be used in the following photodynamic experiments.
 In a time-lapse experiment (Supplementary video 1 and 2) it is 
clearly visible how damaged cells round up before the uptake of PI and 
remain PI positive. On healthy cells, Hexvix alone without blue light 
illumination did not harm either the cancer or non-cancer cells over 
the full range of concentrations (Figure 1A).
 However, if blue light illumination follows Hexvix uptake 
(Figure 1B), cell death occurs, more notoriously on cancer cells 
(5637) than in the control cell line (MDCK). At the highest Hexvix 
concentration (400μM), control cells showed 73% cell death, but fell 
beneath 10% (background level) in lower concentrations. The cancer 
cell line showed cell death at 93% at the highest concentration of 
Hexvix, followed by a slow decline of 79, 78, 38 and 18% cell death at 
the other corresponding Hexvix concentrations. Thus, there is a broad 
window of concentrations (5-50μM) at which the combined effect of 
Hexvix and blue light kill cancer cells but not non-cancer cells.
 In cancer cells treated with 10μM Hexvix cell death was not 
obvious, but cells stopped moving and shrank as a stress response. 
Interestingly, such cells demonstrated Hexvix fluorescence signal 
under these conditions, indicating intracellular uptake. Only cells with 
the strongest observed signal (therefore increased Hexvix uptake) die.
 Based on these results, 400μM was used as a positive control 
concentration for Hexvix, where cell death would be triggered in 
monolayer cultures independently of the cell type treated. Also 
50-5μM concentrations were used in order to reveal phototoxicity 
profiles for each cell lines in order to detect the threshold value of 
concentration for each cell type.
 These results show that it is not light alone (or light intensity) that 
kills cells but its combination with Hexvix, as the absence of the com-
pound (control) shows low cell death unrelated to the treatment.
Cell line Accuracy (%)
MDCK 86.9
HEK293 88.6
5637 85.9
PC3 88.7
SW480 93.5
MDA-MB-231 93.9
Table 2: Percent accuracy of  automated cell counting using Cell Profiler software 
compared to manual counting for each cell line studied, using pre-processed bright 
field DIC images.
Supplementary Video 1: Time-lapse video of  non-cancer Kidney cells (MDCK) 
treated with 400 μM of  Hexvix and 5 sec blue light (405 nm) illumination every 10 
minutes, over a period of  8 hours. Green= PAPs, red = PI, scale bar = 100μm.
Supplementary Video 2: Time-lapse video of  bladder cancer cells (5637) treated 
with 400 μM of  Hexvix and 5 sec blue light (405 nm) illumination every 10 minutes, 
during 8 hours. Green= PAPs, red = PI, scale bar = 100 μm.
Video Clip
http://www.henrypublishinggroups.com/supplementary-video-1/
Video Clip
http://www.henrypublishinggroups.com/supplementary-video-2/
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Hexvix+light killed bladder cancer 
cells but not non-cancer cells at lower 
illumination doses
 As an illumination dose at specific light wavelength is a factor 
effecting photodynamic therapy [2], cells were treated with previously 
defined concentrations of Hexvix using blue light impulses at 
varying time lengths (Figure 2). After eight hours of cumulative 
treatment non-cancer cells showed a higher tolerance when compared 
to cancer cells to specific illumination throughout all Hexvix 
concentrations.
 Three-second exposure times of blue light with both 400μM and 
50μM Hexvix concentrations triggered more than 80% cell death. 
Similar values were observed using five-second exposure times at the 
same concentrations. Using a one second exposure time every 10 min-
utes, 400μM Hexvix treatment reached 64.7% cell death in the 5637 
cell line. This was 60% higher than the response observed in MDCK 
cells (Figure 2).
Hexvix photodynamic treatment is 
effective against three different cancer cell 
types
 Four cancer cell lines: bladder cancer (5637), Prostate Cancer 
(PC3), colon cancer (SW480) and breast cancer (MDA-MB-231) 
as well as two non-cancerous cell lines (MDCK and HEK293) were 
tested in order to investigate the photodynamic effect of Hexvix 
on each of them. Figure 3 shows that each cancer cell line has a 
specific response to Hexvix photodynamic treatment, which was 
efficient against bladder cancer (5637), Prostate Cancer (PC3) and 
colon cancer (SW480) and showed a decreased effect against breast 
cancer (MDA-MB-231) and non-cancerous cell lines (MDCK and 
HEK293).
 The second non-cancer cell line tested, HEK293, had a higher 
sensitivity to the photodynamic effect of Hexvix when compared to 
MDCK cells. This cell line showed a 74% and 60% cell death at 400μM 
and 50μM Hexvix respectively, using the higher dose of blue light 
(five seconds) exposure (Figure 3B). With three-second light exposure, 
cell death reached 78% at 400μM Hexvix concentration, almost 70% 
higher than MDCK cells under the same conditions. This increased 
sensitivity represents a problem in the potential application of Hexvix 
as a photosensitizer for photodynamic therapy, as the treatment 
could also damage normal tissue with this level of sensitivity. On the 
other hand, results with breast cancer cells (MDA-MB-231, Figure 3D) 
show a low sensitivity to photodynamic treatment, when compared to 
bladder cancer cells (positive control). At three second light exposure, 
there was a 40% cell death rate for this cell line, 46% lower than the 
5637 cell line and 38% lower than HEK293. This decreased sensitivity 
to photodynamic treatment with Hexvix could be a problem in 
clinical applications if highly sensitive normal tissue is combined with 
low sensitivity malignant tissue.
Figure 1: Effect of  Hexvix concentration on cell survival.
MDCK and 5637 cells were treated with 400, 50, 25, 10 or 5μM Hexvix and 
monitored for 8 hours. A) No blue light illumination, B) 5 sec blue light (405 nm) 
illumination every 10 minutes. Dotted line indicates 80%. A small amount of  dead 
cells was present at the beginning of  the experiment, independent of  Hexvix or 
illumination treatment. The graph shows mean ± SEM, n=1 triplicate. *** p> 0.001, 
* p> 0.05.
Figure 2: Cell survival rate following Hexvix treatment.
MDCK and 5637 cells were treated with 400, 50, 25, 10 or 5 μM Hexvix and then 
exposed to blue light (405nm) repetitively with 1-5 sec impulses every 10 minutes 
over the course of  8 hours (a total of  48 impulses). MDCK cells were more tolerant 
than 5637 cells to photodynamic treatment. The graph shows mean ± SEM, n=1 
triplicate. *** p > 0.001, ** p > 0.01, * p > 0.05.
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 Figure 3 highlights that cancer cell lines PC3 and SW480 are 
highly sensitive to photodynamic treatment using Hexvix, even 
higher than the positive control 5637 cell line. Prostate Cancer (PC3) 
cells show 98% and 97% cell death at 400μM and 50μM Hexvix 
respectively when treated with five-second exposures to blue light. 
When treated with three-second exposures of blue light cell death 
reaches 90% and 87% at the same Hexvix concentrations. This 
rate of cellular toxicity is ideal for optimal photodynamic therapy 
application, where cancerous cells are surrounded by normal tissue 
with low sensitivity to the same treatment. Similar to these results, 
colorectal cells (SW480) show 98% and 94% cell death at 400μM and 
50μM Hexvix respectively when treated with five second exposures 
to blue light. When treated with three-second exposures, cell death 
reaches up 83% and 88% at the same Hexvix concentrations. These 
two cancer cell lines also show a response at one-second exposures, 
with cell death at 80% in SW480 cells at 5μM and 25μM Hexvix 
treatment. The PC3 cell line also shows a response under these 
conditions with 73% and 78% cell death respectively.
 Strong morphological changes were observed in the different 
cell lines during photodynamic treatment with Hexvix and blue light, 
similar for all cell lines. Figure 4 shows the three-step process that 
was observed in every cell line from normal state to death. When the 
photodynamic treatment is effective, cells die and follow a series of 
morphological changes: firstly, cells shrink and partially detach from 
the surface, taking a rounded shape; during this process stress fibers 
can be observed in some cells (Figure 4, PC3 cells). Later, blebs 
formation can be observed; these blebs grow and fuse, looking at the 
end like a halo around the cells. After this, cells appear flattened and PI 
emission show up, which means cell membrane becomes permeable 
confirming the cell death [10].
 As seen in Figure 4, the morphological changes were 
observed in all cell lines studied when death is the final fate of the cell. 
This indicates that all cell lines, with no matter of its origin, follow 
similar mechanism that drives to cell death when photodynamically 
treated using Hexvix and blue light illumination.
Discussion
 This study proposes that Hexvix treatment combined with blue 
light (405nm) has possible applications as a photosensitizer drug on 
different cancer cell lines, not only bladder cancer cells, for clinical 
photodynamic therapy. In order to test the potential of Hexvix, an 
image-based assay was designed and applied to two non-cancer 
cell lines and four cancer cell lines of different origin. Hexvix 
photodynamic treatment was strongly effective on three cancer cell 
lines tested (bladder, prostate and colon cancer cell lines), with a low 
effect observed in non-cancer cells (dog kidney and human embryon-
ic kidney) along with breast cancer cells, within a concentration range 
from 400μM to 5μM Hexvix combined with a light dose exposure 
time from five to one second every 10 minutes. These results suggest 
Hexvix has a potential to label and kill other cancer cells, in 
addition to bladder cancer cells.
 Figure 3 summarizes the results obtained for the 6 cell lines tested, 
showing different response patterns. Prostate Cancer (PC3) and colon 
cancer (SW480) cell lines showed the highest cell death rates with 
Figure 3: Effect of  blue light combined with Hexvix (photodynamic treatment) on 
cell survival in six different cell lines. (A-F) Indicated cells were treated with 400, 50, 
25, 10 or 5μM of  Hexvix for 60 to 90 minutes followed by 5, 3 or 1 sec blue light 
(405nm) illumination every 10 minutes and monitored over the course of  8 hours. 
A) MDCK; B) HEK293; C) 5637; D) MDA-MB-231; E) PC3; F) SW480. The graph 
shows mean ± SEM, n=1 triplicate. *** p > 0.001, ** p > 0.01, * p > 0.05.
Figure 4: Morphological changes observed on different cell lines during 
photodynamic treatment using Hexvix. Photodynamic treatment using 400μM 
Hexvix combined with 5 sec 405nm light exposure was monitored for 6 cell lines. 
In the process of  cell death, cells shrink and show stress fibers (black arrows) and 
“blebs” formation (white arrows). Cell death is confirmed by PI emission (red). Scale 
bar = 20μm.
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Hexvix treatment, suggesting potential clinical applications of Hexvix 
photodynamic effect for treatment of these diseases. Among 
non-cancer cells a variation of sensitivity to Hexvix was observed. 
The Human Embryonic Kidney (HEK293) cell line showed an 
increased sensitivity to treatment when compared to the MDCK cell 
line, though still less sensitive than cancer cells. This relatively high 
sensitivity could represent a problem for the potential application 
of Hexvix as a photosensitizer for photodynamic therapy, as the 
treatment could damage normal tissues.
 In Figure 3E and 3F, the calculated cell death values were 
below 100% even in such sensitive cell lines, where total cell deaths 
was expected (and most probably happened) at the highest concentra-
tion Hexvix and the highest blue light dose. This could be explained by 
the systematical error associated with the cell counting method used 
in this image-based assay (Table 2). For the values discussed here, an 
approximate 10% of accuracy error must be considered which may 
lead to these differences in the values presented. However, difference 
between treated cells and controls without Hexvix compound are still 
statistically significant, indicating the photodynamic effect of Hexvix 
along with blue light treatment.
 As mentioned before, the mechanism for preferential Hexvix 
uptake by malignant cells is not yet clear, but it is proposed that it 
relies on the proliferative properties of the cells [5,6]. According to 
this, the higher phototoxic effect of Hexvix on the HEK293 cell line 
may be explained by its embryonic nature, in contrast to MDCK 
cells and their different response to Hexvix treatment. It must also be 
noticed that HEK293 cells are a transformed cell line with many 
altered regulatory pathways, usually being considered aa low-tumori-
genic cell line [11]. Performing a test in a primary culture of non-can-
cer urothelial mucosa could be an interesting alternative as a control 
for the photodynamic therapy application with Hexvix, in order to 
define the appropriate dose for each case.
 Photo-damage and cytotoxicity depend on many factors such 
as the type and concentration of the sensitizer used, sensitizer 
localization in the cell, oxygen availability, light exposure dose, 
light fluence (radiant energy received by cells surface) and time of 
incubation before light exposure [1]. During routine blue light 
cystoscopy the light doses applied vary. Typical total light doses (white 
light and blue light) range between 180J and 360J at an intensity of 
0.25 mW/cm2 [4]. This light intensity is more than 100 times lower 
than the maximum laser intensity estimated during this study 
(100 mW/cm2). Even so, the phototoxic effect of Hexvix is only 
observed when combined with blue light illumination (Figure 1). In 
the absence of blue light during treatment with 400μM Hexvix, little to 
no cell death was observed, nor was any signal of cell distress such as 
shrinking; in these conditions cells behave normally, moving around 
and dividing (data not shown). These results indicate that the 
photodynamic effect of Hexvix is only generated if Hexvix and 
blue light are combined as treatment on these cells, but not if these 
components are applied alone, also indicating that Hexvix acts in a 
concentration dependent manner. Other factors, however, such as 
tissue heating caused by the intense light and phototoxicity not 
triggered by the photo sensitizer, must be considered, as such factors 
could participate in total cell death observed in Hexvix 
photodynamic treatment. Figure 2 results also indicate that the 
phototoxic effect depends not only on Hexvix concentration but also 
on light exposure times. Therefore this defines the threshold dose 
for treating cancer cells without damaging normal tissue. Moreover, 
different cell lines exhibit different responses to Hexvix treatment, 
indicating that other cell lines might be more or less sensitive to 
photodynamic treatment using Hexvix as photo sensitizer.
 However accumulation of oxygenated products inside malignant 
cells leads to cell death [1,2], further experiments are required to de-
termine which radical is the most responsible for cell death due to the 
Hexvix photodynamic effect. Photodynamic effect occurs under dif-
ferent mechanisms [1], and reactions occur simultaneously and pre-
dominance of one or the other depends on the type of photosensitizer, 
its concentration along with oxygen and substrate concentration, and 
the binding affinity of these molecules [12].
 Significant changes in the morphology of the cells were observed 
along Hexvix photodynamic treatment. Cell shrinkage, a hallmark 
of apoptosis, can be observed in Figure 4, followed by what could 
be the generation of apoptotic or necrotic blebs, based on literature 
description of the cell death process on mammalian cells [11]. These 
results agree with literature, that describes that cell death by photo-
toxicity leads to tumor cell death via an apoptotic, necrotic or auto-
phagic mechanisms [2]. Further studies on Hexvix phototoxic effect 
should include pathway research using apoptotic or necrotic markers, 
to elucidate which is the mechanism involved in cell death triggered 
by Hexvix photodynamic treatment.
 The Hexvix compound does not meet all the requirements 
of an optimal photosensitizer; for example its absorption is in the 
range of the 380-450nm, far from the 650nmto 805nm proposed by 
Plaetzer [12]. The overall results indicate that response to Hexvix 
photodynamic treatment using blue light is tissue-dependent and the 
sensitivity to the treatment may vary. However, the mechanism lying 
behind the interaction between the photosensitizer drug and 
malignant tissue is still not fully clear. Nonetheless, results shown here 
are promising to propose Hexvix as a candidate for its application 
in photodynamic therapy, to treat different types of cancer. Further 
studies on the phototoxic effect of Hexvix should include the 
sensitivity ratio of tumour and the surrounding tissue in vivo and 
in vivo experiments after tumour resectioning, in order to set up 
treatment parameters such as the appropriate Hexvix concentration 
and blue light exposure times, in the light of possible future clinical 
applications along with broadening its application to other cell types.
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Supplementary Methods
Image processing
 The pipeline of image processing for bright field and fluorescence 
images is depicted in Supplementary Figure 2. DIC images acquired 
were firstly processed using Image J/Fiji software (National Institute 
of Health, USA), where a flat field correction for DIC was applied to 
images using a Gaussian blur of a radius of 100 px and dividing this 
image to its original using the Calculator Plus tool in Fiji, using as 
k1 value the mean gray intensity value from the blurred image. After 
this, the image was sharpened to exploit texture from DIC image using 
Sharpen process tool and finally the contrast was enhanced automati-
cally using Enhance Contrast process tool, with a saturated pixel value 
of 0.5%.
 Processed DIC images were used for automated total cell counting 
using Cell Profiler software version 2.1.1 (National Institute of Health, 
USA), originally designed for fluorescence images. To do so, imag-
es were also processed in this software according to the pipeline 
(Supplementary Figure 2). Image Load module was used to load the 
TIFF movies generated, using default configuration for TIFF movies 
with one channel. For processing, Image Math module using invert 
operation was applied to invert image colors, Enhance or 
Supress- Features module was used to enhance DIC features with a 
smoothing scale of 0.5, shear angle of 0.0 and decay value of 0.75. 
Enhance Edges module was used based on the Prewitt edge-finding 
method, as it was the one that performed the best, enhancing in all 
directions. After processing, cell segmentation was performed using 
the Identify Primary Objects module with a diameter of the objects 
of minimum 20px and maximum of 100px. Objects outside this range 
were excluded from counting. Objects touching the border of the 
image were not discarded and the thresholding strategy was adopted 
with a background method and an adaptive window size was 
calculated by image size. The smoothing method for thresholding 
was automatic with a corrector factor value as 1.0 with a minimum of 
0.0 and a maximum of 1.0, as this configuration performed the best. 
The method to distinguish and draw dividing lines between clumped 
objects was based on the shape of the objects and the system was 
setup to automatically calculate the size of the smoothing filter after 
declumping and to calculate the minimum allowed distance between 
local maxima. No low-resolution images were used to find the local 
maxima or were outlines of the identified objects retained. After 
image segmentation Export to Spreadsheet module was used to save 
the results obtained, using the default settings.
 Fluorescence images corresponding to PI signal in dead cells 
were processed using Fiji software to subtract background, using 
background subtraction tool with rolling ball of 50px. After this, 
images were used for dead cell counting using Cell Profiler software. 
Image Load module was used to load the TIFF video files 
generated, using default configuration for TIFF videos with one 
channel. For processing, Enhance or Supress Features module was 
used to enhance circles with a feature size of 10, in order to prevent 
detection of smaller circles inside the stained nuclei. Also Enhance 
Edges module was used, based on the Sobel edge-finding method 
enhancing in all directions. After processing, cell segmentation 
was performed using the Identify Primary Objects module with a 
diameter of the objects of minimum 20 px and maximum of 100 px, 
objects outside this range were excluded from counting. Objects touch-
ing the border of the image were discarded and the thresholding strat-
egy was Adaptive with a Background method, where adaptive window 
size was calculated by image size. Smoothing method for thresholding 
was Automatic with a corrector factor value as 1.0 with a minimum 
of 0.0 and a maximum of 1.0, as this configuration performed the 
best. The method used to distinguish and draw dividing lines between 
clumped objects was based on the intensity of the objects and the 
system was setup to automatically calculate the size of the smoothing 
filter after declumping and to calculate the minimum allowed distance 
between local maxima. No low-resolution images were used to find 
the local maxima nor were outlines of the identified objects retained. 
After image segmentation Export to Spreadsheet module was used to 
save the results obtained, using the default settings.
Supplementary figure 2: Image processing pipeline. Bright field and fluorescence 
images were processed in order to enhance automated counting, using Image J/Fiji 
and Cell Profile software. Quantitative and qualitative (time-lapse) data was acquired 
from these images.
